Literature DB >> 11331761

Structure of melanoma inhibitory activity protein, a member of a recently identified family of secreted proteins.

J C Lougheed1, J M Holton, T Alber, J F Bazan, T M Handel.   

Abstract

Melanoma inhibitory activity (MIA) is a 12-kDa protein that is secreted from both chondrocytes and malignant melanoma cells. MIA has been reported to have effects on cell growth and adhesion, and it may play a role in melanoma metastasis and cartilage development. We report the 1.4-A crystal structure of human MIA, which consists of an Src homology 3 (SH3)-like domain with N- and C-terminal extensions of about 20 aa. each. The N- and C-terminal extensions add additional structural elements to the SH3 domain, forming a previously undescribed fold. MIA is a representative of a recently identified family of proteins and is the first structure of a secreted protein with an SH3 subdomain. The structure also suggests a likely protein interaction site and suggests that, unlike conventional SH3 domains, MIA does not recognize polyproline helices.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331761      PMCID: PMC33244          DOI: 10.1073/pnas.091601698

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  The identification of conserved interactions within the SH3 domain by alignment of sequences and structures.

Authors:  S M Larson; A R Davidson
Journal:  Protein Sci       Date:  2000-11       Impact factor: 6.725

2.  Characterization of a transcription factor binding site, specifically activating MIA transcription in melanoma.

Authors:  M Golob; R Buettner; A K Bosserhoff
Journal:  J Invest Dermatol       Date:  2000-07       Impact factor: 8.551

3.  Structural basis for phosphoserine-proline recognition by group IV WW domains.

Authors:  M A Verdecia; M E Bowman; K P Lu; T Hunter; J P Noel
Journal:  Nat Struct Biol       Date:  2000-08

4.  Improved methods for building protein models in electron density maps and the location of errors in these models.

Authors:  T A Jones; J Y Zou; S W Cowan; M Kjeldgaard
Journal:  Acta Crystallogr A       Date:  1991-03-01       Impact factor: 2.290

Review 5.  Protein modules and signalling networks.

Authors:  T Pawson
Journal:  Nature       Date:  1995-02-16       Impact factor: 49.962

6.  MOLMOL: a program for display and analysis of macromolecular structures.

Authors:  R Koradi; M Billeter; K Wüthrich
Journal:  J Mol Graph       Date:  1996-02

7.  Critical residues in an SH3 domain from Sem-5 suggest a mechanism for proline-rich peptide recognition.

Authors:  W A Lim; F M Richards
Journal:  Nat Struct Biol       Date:  1994-04

8.  Mouse CD-RAP/MIA gene: structure, chromosomal localization, and expression in cartilage and chondrosarcoma.

Authors:  A K Bosserhoff; S Kondo; M Moser; U H Dietz; N G Copeland; D J Gilbert; N A Jenkins; R Buettner; L J Sandell
Journal:  Dev Dyn       Date:  1997-04       Impact factor: 3.780

9.  Automated MAD and MIR structure solution.

Authors:  T C Terwilliger; J Berendzen
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-04

10.  Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin.

Authors:  G D Van Duyne; R F Standaert; P A Karplus; S L Schreiber; J Clardy
Journal:  J Mol Biol       Date:  1993-01-05       Impact factor: 5.469

View more
  21 in total

1.  Automated protein crystal structure determination using ELVES.

Authors:  James Holton; Tom Alber
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-29       Impact factor: 11.205

2.  Application of sparse NMR restraints to large-scale protein structure prediction.

Authors:  Wei Li; Yang Zhang; Jeffrey Skolnick
Journal:  Biophys J       Date:  2004-08       Impact factor: 4.033

Review 3.  Protein export at the ER: loading big collagens into COPII carriers.

Authors:  Vivek Malhotra; Patrik Erlmann
Journal:  EMBO J       Date:  2011-08-31       Impact factor: 11.598

4.  Reduced cholesterol and triglycerides in mice with a mutation in Mia2, a liver protein that localizes to ER exit sites.

Authors:  Jeffrey L Pitman; David J Bonnet; Linda K Curtiss; Nicholas Gekakis
Journal:  J Lipid Res       Date:  2011-08-01       Impact factor: 5.922

5.  Solution structure and dynamics of melanoma inhibitory activity protein.

Authors:  Julie C Lougheed; Peter J Domaille; Tracy M Handel
Journal:  J Biomol NMR       Date:  2002-03       Impact factor: 2.835

6.  Backbone dynamics of the human MIA protein studied by (15)N NMR relaxation: implications for extended interactions of SH3 domains.

Authors:  Raphael Stoll; Christian Renner; Reinhard Buettner; Wolfgang Voelter; Anja-Katrin Bosserhoff; Tad A Holak
Journal:  Protein Sci       Date:  2003-03       Impact factor: 6.725

7.  Human melanoma inhibitory protein binds to the FN12-14 Hep II domain of fibronectin.

Authors:  King Tuo Yip; Xueyin Zhong; Nadia Seibel; Oliver Arnolds; Miriam Schöpel; Raphael Stoll
Journal:  Biointerphases       Date:  2017-05-31       Impact factor: 2.456

8.  Misexpression of MIA disrupts lung morphogenesis and causes neonatal death.

Authors:  Sui Lin; Machiko Ikegami; Yan Xu; Anja-Katrin Bosserhoff; Alvin M Malkinson; John M Shannon
Journal:  Dev Biol       Date:  2008-02-15       Impact factor: 3.582

9.  A genome-wide RNA interference screen identifies two novel components of the metazoan secretory pathway.

Authors:  Franz Wendler; Alison K Gillingham; Rita Sinka; Cláudia Rosa-Ferreira; David E Gordon; Xavier Franch-Marro; Andrew A Peden; Jean-Paul Vincent; Sean Munro
Journal:  EMBO J       Date:  2009-11-26       Impact factor: 11.598

10.  Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer.

Authors:  Jeroen R Mesters; Cyril Barinka; Weixing Li; Takashi Tsukamoto; Pavel Majer; Barbara S Slusher; Jan Konvalinka; Rolf Hilgenfeld
Journal:  EMBO J       Date:  2006-02-09       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.